Z-1540-2021 Class II Terminated

Recalled by Meridian Bioscience Inc — Cincinnati, OH

FDA device recall Z-1540-2021 was initiated by Meridian Bioscience Inc on Apr 8, 2021 and is designated Class II. Reason for recall: Emergency Use Application (EUA) application withdrawn as false negative results reported The recall status is terminated (terminated Oct 26, 2021). Affected quantity: 376 kits of the Revogene SARS-CoV-2 assay.

Recall details

Product Type
Devices
Report Date
May 19, 2021
Initiation Date
Apr 8, 2021
Termination Date
Oct 26, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
376 kits of the Revogene SARS-CoV-2 assay

Product description

Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene¿ instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) specimens from individuals suspected of COVID-19

Reason for recall

Emergency Use Application (EUA) application withdrawn as false negative results reported

Distribution pattern

Nationwide

Code information

All lot numbers

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1540-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1540-2021. Report a data issue: hello@regdatalab.com.